期刊文献+

地塞米松和他克莫司对HaCaT细胞热休克蛋白90表达影响的研究 被引量:3

Effects of dexamethasone or tacrolimus on expression of heat shock protein 90 of HaCaT cells in vitro
下载PDF
导出
摘要 目的:比较地塞米松和他克莫司对HaCaT细胞热休克蛋白90(ISP90)表达的影响,并探讨其潜在的临床意义。方法:以含10^(-6)mol/L地塞米松或10^(-6)mol/L他克莫司的DMEM(高糖)培养基培养细胞,在24 h和48 h的不同时相点,采用Real timePCR和Western blotting检测tSP90的表达。结果:地塞米松作用24 h后,HSP90 mRNA和蛋白表达水平均升高,48 h后进一步升高(P<0.05);而他克莫司作用于HaCaT细胞后的不同时相点,tSP90 mRNA和蛋白水平与未处理组相比差异均无统计学意义(P>0.05)。结论:地塞米松可上调角质形成细胞中HSP90的表达,他克莫司不影响角质形成ll胞HSP90的表达。 Objective: To investigate the effects of dexamethasone or tacrolimus on heat shock protein 90 (HSP90) expression in HaCaT cells in vitro. Methods: The expression of HSP90 of the HaCaT cells treated with dexamethasone at 10^-6 mol/L or tacrolimus at 10^-6 mol/L were assessed by RT-real time PCR and Western blotting at settled duration. Results: Comparing with negative control, the expression of HSP90 was significantly increased in the cells after the 24 h and 48 h treatment of dexam- ethasone (P〈 0.05), whereas the effect was not observed in the cells treat with tacrolimus. Conclusions: Dexamethasone could up-regulate the HSP90 expression in HaCaT cells, but tacrolimus did not.
出处 《临床皮肤科杂志》 CAS CSCD 北大核心 2012年第1期11-13,共3页 Journal of Clinical Dermatology
基金 第三军医大学第二附属医院1520人才基金(2006-188号)资助项目
关键词 地塞米松 他克莫司 角质形成细胞 热休克蛋白 dexamethasone tacrolimus keratinocytes heat shock protein
  • 相关文献

参考文献12

  • 1郁博,何威,张斌,杨玲,吴军.地塞米松对HaCaT细胞糖皮质激素受体α表达的影响[J].临床皮肤科杂志,2008,37(4):216-218. 被引量:9
  • 2杨玲,何威,张斌.他克莫司对HaCaT细胞核因子-κB和糖皮质激素受体表达的影响[J].中华皮肤科杂志,2010,43(6):385-389. 被引量:5
  • 3Kang KI,Meng X,Devin-Leclerc J,et al.The molecular chaperone Hsp90 can negatively regulate the activity of a glucocorticosteroid-dependent promoter[J].Proc Nat Acad Sci USA,1999,96(4):1439-1444.
  • 4Qian X,Zhu Y,Xu W,et al.Glucocorticoid receptor and heat shock protein 90 in peripheral blood mononuclear cells from asthmatics[J].Chin Med J (Engl),2001,114(10):1051-1054.
  • 5Vijayan MM,Raptis S,Sathiyaa R,et al.Cortisol treatment affects glucocorticoid receptor and glucocorticoid-responsive genes in the liver of rainbow trout[J].Gen Comp Endocrinol,2003,132(2):256-263.
  • 6Ranta F,Dufer M,Stork B,et al.Regulation of calcineurin activity in insulin-secreting cells:stimulation by Hsp90 during glucocorticoid-induced apoptosis[J].Cell Signal,2008,20 (10):1780-1786.
  • 7Chant ID,Rose PE,Morris AG.Analysis of heat-shock protein expression in myeloid leukaemia cells by flow cytometry[J].Br J Haematol,1995,90(1):163-168.
  • 8Tago K,Tsukahara F,Naruse M,et al.Hsp90 inhibitors attenuate effect of dexamethasone on activated NF-kappaB and AP-1[J].Life Sci,2004,74(16):1981-1992.
  • 9Elbi C,Walker DA,Romero G,et al.Molecular chaperones function as steroid receptor nuclear mobility factors[J].Proc Natl Acad Sci USA,2004,101(9):2876-2881.
  • 10Pratt WB,Galigniana MD,Harrell JM,et al.Role of hsp90 and the hsp90-binding immunophilins in signaling protein movement[J].Cell Signal,2004,16(8):857-872.

二级参考文献15

  • 1杨玲,何威,黎智,吴军,林自华,何云志,黄海.糖皮质激素受体-α、核因子-κB、肿瘤坏死因子-α和白介素-1β在慢性皮炎中的表达[J].临床皮肤科杂志,2006,35(5):291-293. 被引量:4
  • 2李波,白祥军,王海平.地塞米松对人单核细胞糖皮质激素受体蛋白表达的影响[J].中华急诊医学杂志,2006,15(6):525-528. 被引量:15
  • 3Sánehez-Vega B,Krett N,Rosen ST,et al.Glucocorticoid receptor transcriptional isoforms and resistance in multiple myeloInn cells.Mol Cancer Ther,2006,5(12):3062-3070.
  • 4Prima V,Depoix C,Masselot B et al.Alteration of the glucocorticoid receptor subcellular localization by non steroidal compounds.J Steroid Biochem Mol Biol,2000,72(1-2):1-12.
  • 5Uu H,Ma Y,Pagliari LJ,et al.TNF-alpha-induced apoptosis of macrophages following inhibition of NF-kappa B:a central role for disruption of mitochondria.J Immanol,2004,172(3):1907-1915.
  • 6Kalthoff FS,Winiski A,Fichtinger P,et al.Differential inhibition of primary versus preactivated T cells by pimecrolimus but not by tacrolimus in vitro.Int Arch Allergy Immunol,2007,142(3):255-264.
  • 7Novak N,Kwiek B,Bieber T,The mode of topical immunomodulators in the immunological network of atopic dermatitis.Clin Exp Dermatol,2005,30(2):160-164.
  • 8Lan CC,Chen GS,Chiou MH,et al.FK506 promotes melanocyte and melanoblast growth and creates a favourable milieu for cell migration via keratinocytes:possible mechanisms of how tacrolimus ointment induces repigmentation in patients with vitiligo.Br J Dermatol,2005,153(3):498-505.
  • 9H(a)m(a)l(a)inen M,Korhonen R,Moilanen E.Calcineurin inhibitors down-regulate iNOS expression by destabilizing mRNA.Int Immunopharmacol,2009,9(2):159-167.
  • 10McKay LI,Cidlowski JA.Cross-talk between nuclear factor-kappa B and the steroid hormone receptors:mechanisms of mutual antagonism.Mol Endocrinol,1998,12(1):45-56.

共引文献10

同被引文献32

  • 1刘玲玲,窦侠,闻卫兢,郑志忠,王宝玺,林麟,曾凡钦,顾军,朱学骏.他克莫司软膏治疗成人特应性皮炎疗效和安全性研究[J].中华皮肤科杂志,2005,38(7):406-409. 被引量:29
  • 2孙传兴.临床疾病诊断依据治愈好转标准[M].2版.北京:人民军医出版社,2006.
  • 3Kang KI, Meng X, Devin-lecerc J, et al. The molecular chaperone Hsp90 can negatively regulate the activity of a glucocorti-costeroid-dependent promoter [J]. Proc Nat Acad Sci USA, 1999,96(4) : 1439-1444.
  • 4Qian X,Zhu Y,Xu W, et al . Glucocorticoid receptor and heat shock protein 90 in peripheral blood mononuclear cells from asthmatics[J]. Chin Med J (Engl), 2001,114(14) : 1051-1054.
  • 5Hanifin JM. Ling MR, Langley R , et al . Tacrdimus oimtment for the treatment of atopie dermatitis in adult patients : part Ⅰ,efficaey[J]. J Am Acad Dematol , 2001,44(1 suppl) : S28- S38.
  • 6Soter NA , Fleischer AB Jr, Webster GF , et al . Taerolimus ointment for the treatment of atopic dermatitis in adult patients : part Ⅱ, safety[J] . J Am Acad Dermatol, 2001,44 (1 Suppl) : S39-S46.
  • 7Olhnberg A, Sharma S, von Bubnoff D, et al. Topical tacrolimas(FK505) leads to profound phenotypic and functional alterations of epidermal antigen-presenting dendritic cells in atopic dermatitis [J]. AUergy Clin Immunol, 2001,107 (3) : 519-529.
  • 8Marsland AM, Griffiths CE. The macrolide immuno suppressants in dermatology mechanisms of action[J]. Eur J Dermatol, 2002,12 (6) : 618-622.
  • 9Leung DY, Bogamiewicz M, Howell MD, et al. New insights into atopic dermatitis[J]. J Clin Invest, 2004,113 (5) : 651- 657.
  • 10Hanifin JM,Paller AS,Eichenfield L,et al. Efficacy and safety of ta- crolimus ointment treatment for up to 4 years in patients with atopic dermatitis[J]. J AM Aead Dermatol,2005,53(2 Suppl 2) :S186-S194.

引证文献3

二级引证文献27

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部